BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anlon Healthcare Ltd IPO is open
Apply for the Anlon Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

19218

543998

VALIANTLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VALIANT LABORATORIES LTD performance

Today’s low

Today’s high

₹ 85.61 ₹ 90.79
₹ 87.09

52 week low

52 week high

₹ 69.84 ₹ 123.98
₹ 87.09

Open Price

₹ 86.98

Prev. Close

₹ 86.52

Volume (Shares)

52997.00

Total traded value

₹ 46.15

Upper Circuit

₹ 95.17

Lower Circuit

₹ 77.86

info

VALIANT LABORATORIES LTD Share Price Update

As of the latest trading session, VALIANT LABORATORIES LTD share price is currently at ₹ 87, which is up by ₹ 0.48 from its previous closing. Today, the stock has fluctuated between ₹ 85.61 and ₹ 90.79. Over the past year, VALIANT LABORATORIES LTD has achieved a return of -18.23 %. In the last month alone, the return has been -3.66 %. Read More...

Investment Returns

Over 1 Month -3.66% Over 3 Months -10.23% Over 6 Months 15.54% Over 1 Year -18.23%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VALIANT LABORATORIES LTD fundamentals


  • Market cap (Cr)

    473.00

  • P/E Ratio (TTM)

    720.25

  • Beta

    0.72

  • Book Value / share

    58.15

  • Return on equity

    -1.70%

  • EPS (TTM)

    0.12

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.82

info icon alternate text
  • Market cap (Cr)

    477.80

  • P/E Ratio (TTM)

    720.25

  • Beta

    0.73

  • Book Value / share

    58.15

  • Return on equity

    -1.70%

  • EPS (TTM)

    0.12

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.82

info icon alternate text

VALIANT LABORATORIES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 51.01
Operating Expense 49.23
Net Profit 1.82
Net Profit Margin (%) 3.56
Earnings Per Share (EPS) 0.42
EBITDA 3.03
Effective Tax Rate (%) 25.71
Particulars MAR 2025 (Values in Cr)
Revenue 57.77
Operating Expense 54.50
Net Profit 3.24
Net Profit Margin (%) 5.60
Earnings Per Share (EPS) 0.74
EBITDA 4.47
Effective Tax Rate (%) 17.60
Particulars DEC 2024 (Values in Cr)
Revenue 35.23
Operating Expense 35.17
Net Profit 1.60
Net Profit Margin (%) 4.54
Earnings Per Share (EPS) 0.37
EBITDA 1.29
Effective Tax Rate (%) -122.22
Particulars SEP 2024 (Values in Cr)
Revenue 21.48
Operating Expense 28.74
Net Profit -5.98
Net Profit Margin (%) -27.83
Earnings Per Share (EPS) -1.39
EBITDA -4.80
Effective Tax Rate (%) -12.40
Particulars JUN 2024 (Values in Cr)
Revenue 18.88
Operating Expense 21.83
Net Profit -1.01
Net Profit Margin (%) -5.34
Earnings Per Share (EPS) -0.23
EBITDA -0.21
Effective Tax Rate (%) -29.87
Particulars MAR 2025 (Values in Cr)
Revenue 133.36
Operating Expense 140.24
Net Profit -2.15
Net Profit Margin (%) -1.61
Earnings Per Share (EPS) -0.50
EBITDA 0.75
Effective Tax Rate (%) -48.27
Particulars MAR 2024 (Values in Cr)
Revenue 182.05
Operating Expense 192.49
Net Profit 0.34
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.14
EBITDA 1.27
Effective Tax Rate (%) 145.33
Particulars MAR 2023 (Values in Cr)
Revenue 333.91
Operating Expense 300.63
Net Profit 29.00
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 8.91
EBITDA 39.95
Effective Tax Rate (%) 23.96
Particulars MAR 2022 (Values in Cr)
Revenue 291.52
Operating Expense 251.76
Net Profit 27.50
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 16.99
EBITDA 44.26
Effective Tax Rate (%) 34.07
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.51
ROE % -1.71
ROCE % -1.63
Total Debt to Total Equity 0.41
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 28.86
ROCE % 23.73
Total Debt to Total Equity 0.60
EBITDA Margin 11.96
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.52
ROE % -1.70
ROCE % -1.68
Total Debt to Total Equity 0.36
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 33.73
ROCE % 26.00
Total Debt to Total Equity 0.71
EBITDA Margin 11.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.89
ROE % 34.37
ROCE % 37.35
Total Debt to Total Equity 0.39
EBITDA Margin 15.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.36
ROE % 34.53
ROCE % 54.13
Total Debt to Total Equity 0.01
EBITDA Margin 28.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.21
Total Assets 342.68
Total Liabilities 342.68
Total Equity 236.86
Share Outstanding 43450000
Price to Book Ratio 2.67
Return on Assets (%) 0.09
Return on Capital (%) 0.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 212.96
Total Liabilities 212.96
Total Equity 100.49
Share Outstanding 32560000
Price to Book Ratio 0.00
Return on Assets (%) 13.61
Return on Capital (%) 18.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 96.72
Total Assets 324.72
Total Liabilities 324.72
Total Equity 236.88
Share Outstanding 43450000
Price to Book Ratio 2.67
Return on Assets (%) 0.10
Return on Capital (%) 0.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 212.75
Total Liabilities 212.75
Total Equity 100.49
Share Outstanding 32560000
Price to Book Ratio 0.00
Return on Assets (%) 13.62
Return on Capital (%) 18.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 20.13
Total Assets 181.81
Total Liabilities 181.81
Total Equity 71.46
Share Outstanding 16280000
Price to Book Ratio 0.00
Return on Assets (%) 15.12
Return on Capital (%) 20.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.93
Total Assets 106.31
Total Liabilities 106.31
Total Equity 88.58
Share Outstanding 10500000
Price to Book Ratio 0.00
Return on Assets (%) 28.77
Return on Capital (%) 34.4
Particulars MAR 2024 (Values in Cr)
Net Income -0.76
Cash from Operations 0.90
Cash from Investing -143.87
Cash from Financing 152.44
Net change in Cash 10.45
Free Cash Flow 46.77
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 64.85
Cash from Investing -55.16
Cash from Financing -0.93
Net change in Cash -0.05
Free Cash Flow 102.53
Particulars MAR 2024 (Values in Cr)
Net Income -0.75
Cash from Operations 47.80
Cash from Investing -182.72
Cash from Financing 135.79
Net change in Cash 1.85
Free Cash Flow 51.55
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 31.75
Cash from Investing -21.17
Cash from Financing -1.53
Net change in Cash 0.24
Free Cash Flow 38.82
Particulars MAR 2022 (Values in Cr)
Net Income 41.70
Cash from Operations 16.71
Cash from Investing -12.23
Cash from Financing 6.18
Net change in Cash -3.80
Free Cash Flow 23.59
Particulars MAR 2021 (Values in Cr)
Net Income 47.02
Cash from Operations 25.56
Cash from Investing -16.66
Cash from Financing 11.42
Net change in Cash 3.86
Free Cash Flow 27.23
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.64 12.91 1.73 242.47 30.00 / 69.50
BLISS GVS PHARMA LTD 159.70 15.80 1.60 1684.80 105.05 / 190.65
CIPLA LTD 1578.55 23.65 4.08 127508.02 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 329.00 9.27 2.66 968.28 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.64 17.20 4.99 242.47 30.00 / 69.50
AMRUTAJAN HEALTH LTD 697.75 37.00 6.17 2017.24 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8322.70 98.39 27.00 20806.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 159.70 23.87 1.59 1684.80 105.05 / 190.65

VALIANT LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
87.09 0.65 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 87.10
  • 26 Days 91.20
  • 10 Days 88.00
  • 50 Days 94.00
  • 12 Days 88.30
  • 100 Days 95.40
  • 20 Days 90.00
  • 200 Days 100.10
86.87 PIVOT

First Support

85.30

First Resistance

88.09

Second Support

84.08

Second Resistance

89.66

Third Support

82.51

Third Resistance

90.88

RSI

38.51

ADX

7.86

MACD

-2.85

Williams % R

-94.32

Commodity Channel Index (CCI)

-118.94

Date

2025-08-28

Week

11293.00

Same Day

6453.00

Month

36531.00

1 Year

0.73

3 Year

0.98

Over 1 Month

-3.66%

down

Over 1 Year

-18.23%

down

Over 3 Months

-10.23%

down

Over 3 Years

0.00%

down

Over 6 Months

15.54%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

VALIANT LABORATORIES LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
24.54%
Promoter Holdings
74.93%
FII
0.52%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Dhanvallabh Ventures Llp 2.54375E7 (46.84%) Shareholding of Promoter and Promoter Group
Paresh Shashikant Shah 5084612.0 (9.36%) Shareholding of Promoter and Promoter Group
Shantilal Shivji Vora 4073987.0 (7.5%) Shareholding of Promoter and Promoter Group
Santosh Shantilal Vora 4073987.0 (7.5%) Shareholding of Promoter and Promoter Group
Kanchan Shantilal Vora 2018362.0 (3.72%) Shareholding of Promoter and Promoter Group
Money Logix Securities Private Limited 550000.0 (1.01%) Public Shareholding
Rachi Santosh Vora 8662.0 (0.02%) Shareholding of Promoter and Promoter Group
Varsha Paresh Shah 2887.0 (0.01%) Shareholding of Promoter and Promoter Group
Sangita Manoj Jain 1490.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

VALIANT LABORATORIES LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

VALIANT LABORATORIES LTD Share Price

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name 'Valiant Laboratories Limited' through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.

The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.

Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products.

Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an in-house R&D infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL).

In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.

The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.

Parent organization Indian Private
NSE symbol VALIANTLAB
Founded 2021
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Valiant Laboratories Ltd?

Answer Field

Valiant Laboratories Ltd share price is for NSE ₹ 87.00 & for BSE ₹ 87.98 as on Aug 29 2025 03:29 PM.

What is the Market Cap of Valiant Laboratories Ltd Share?

Answer Field

The market cap of Valiant Laboratories Ltd for NSE ₹ 378.01 & for BSE ₹ 382.27 as on Aug 29 2025 03:29 PM.

What is the 52 Week High and Low of Valiant Laboratories Ltd?

Answer Field

The 52 Week High and Low of Valiant Laboratories Ltd for NSE is ₹ 123.98 and ₹ 69.84 and for BSE is ₹ 126.97 and ₹ 70.41.

What is 1 year return for Valiant Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -18.23%.

What is the P/E Ratio of Valiant Laboratories Ltd Share?

Answer Field

As on Aug 29 2025 03:29 PM the price-to-earnings (PE) ratio for Valiant Laboratories Ltd share is 720.25.

What is the PB ratio of Valiant Laboratories Ltd Share?

Answer Field

As on Aug 29 2025 03:29 PM, the price-to-book (PB) ratio for Valiant Laboratories Ltd share is 58.15.

How to Buy Valiant Laboratories Ltd Share?

Answer Field

You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Valiant Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Valiant Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Valiant Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91